Emcure IPO: Subscription at 63%, Is it Time to Jump In?
The Emcure Pharmaceuticals IPO has generated a lot of buzz, and with subscriptions currently at…
The Emcure Pharmaceuticals IPO has generated a lot of buzz, and with subscriptions currently at…
Hold onto your seats, folks! The buzz surrounding "Kalki 2898 AD" is reaching fever pitch,…
Tollywood is on fire! The much-anticipated Kalki 2898 AD has stormed the North American box…
Tired of the same old boring stickers? You're not alone! That's why WhatsApp is testing…
The government has assured the public that the recently introduced Hindi names for certain criminal…
Let's face it, we all crave open doors. The freedom to explore, the chance to…
Remember Koo? The Indian microblogging platform that burst onto the scene as a "desi" alternative…
Breaking news: Prime Minister Narendra Modi will not be attending the upcoming Shanghai Cooperation Organisation…
A chilling incident in West Bengal has sent shockwaves across the country. A man, identified…
Let's face it, sometimes we all hit a creative roadblock. 🚧 You're staring at a…